Phase 3 Dimethyl Fumarate Trial, Type 1 Diabetes, Adults
Summary
A Phase 3 clinical trial for Dimethyl Fumarate in adults with Type 1 Diabetes has been registered in ClinicalTrials.gov under identifier NCT07548996. The trial is categorized under Phase 3 and appears in the registry sorted by start date. This registration documents the existence and parameters of an interventional study without providing additional trial design details, enrollment numbers, or recruitment status in this entry.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
This entry records the registration of a Phase 3 clinical trial for Dimethyl Fumarate as a treatment for Type 1 Diabetes in adult participants. ClinicalTrials.gov serves as the public registry, and this listing provides the trial identifier (NCT07548996) and phase classification. No compliance obligations, reporting requirements, or regulatory deadlines are established by this registration entry.
Pharmaceutical companies, clinical investigators, and institutional review boards monitoring the clinical trial landscape may use this registry entry to identify active Phase 3 studies in the Type 1 Diabetes therapeutic area. Sponsors conducting competitive intelligence or patient recruitment for related studies should note this trial's registration status.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.